• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在已建立的培美曲塞耐药肺腺癌A549细胞系中,表皮生长因子受体(EGFR)和ErbB3的下调均改善了细胞对培美曲塞的反应。

Downregulation of both EGFR and ErbB3 improves the cellular response to pemetrexed in an established pemetrexed‑resistant lung adenocarcinoma A549 cell line.

作者信息

Yu Zhuang, Li Xiu-Mei, Liu Shi-Hai, Liu Bing, Gao Cai-Hong, Hou Xin

机构信息

Department of Oncology, The Affiliated Hospital of Qingdao University, Qingdao 266003, P.R. China.

Central Laboratory, The Affiliated Hospital of Qingdao University, Qingdao 266003, P.R. China.

出版信息

Oncol Rep. 2014 Apr;31(4):1818-24. doi: 10.3892/or.2014.3027. Epub 2014 Feb 18.

DOI:10.3892/or.2014.3027
PMID:24549863
Abstract

Epidermal growth factor receptor (EGFR) and ErbB3 (HER3) play important roles in the regulation of cell proliferation, differentiation, anti-apoptosis and chemoresistance; however, their dysregulation in pemetrexed (PEM) resistance remains unclear. The aim of the present study was to clarify the relationship between PEM resistance and gene expression of EGFR and ErbB3, by establishing the PEM-resistant lung adenocarcinoma A549 cell line, A549/PEM. Compared with A549 cells, the A549/PEM cells were significantly more resistant to PEM (P=0.0024). The downregulation of S phase and arrest at G1 stage were detected in the A549/PEM cell line when compared to the A549 cells (P<0.05). The apoptosis rate of A549/PEM cells was much lower than that of the A549 cells after a 24 h continuous exposure to PEM (P<0.001). Real-time PCR and western blotting demonstrated the overexpression of EGFR and ErbB3 in A549/PEM cells. However, downregulation of EGFR or ErbB3 by lentiviral delivered shRNAs in A549/PEM cells showed no significant correlation with PEM sensitivity while silencing both EGFR and ErbB3 increased the cellular response to PEM in the A549/PEM cells and significantly decreased phosphorylation of STAT3, AKT and ERK. Together, these data suggest that either high expression of EGFR or ErbB3 plays a critical role in the cellular response to PEM in human lung adenocarcinoma cells though EGFR/ErbB3-dependent pathways.

摘要

表皮生长因子受体(EGFR)和ErbB3(HER3)在细胞增殖、分化、抗凋亡及化疗耐药性调控中发挥重要作用;然而,它们在培美曲塞(PEM)耐药中的失调情况仍不清楚。本研究的目的是通过建立PEM耐药的肺腺癌A549细胞系A549/PEM,阐明PEM耐药与EGFR和ErbB3基因表达之间的关系。与A549细胞相比,A549/PEM细胞对PEM的耐药性显著更高(P = 0.0024)。与A549细胞相比,在A549/PEM细胞系中检测到S期下调并停滞于G1期(P < 0.05)。连续24小时暴露于PEM后,A549/PEM细胞的凋亡率远低于A549细胞(P < 0.001)。实时PCR和蛋白质印迹法显示A549/PEM细胞中EGFR和ErbB3过表达。然而,慢病毒递送的短发夹RNA(shRNAs)在A549/PEM细胞中下调EGFR或ErbB3与PEM敏感性无显著相关性,而同时沉默EGFR和ErbB3可增强A549/PEM细胞对PEM的细胞反应,并显著降低信号转导及转录激活因子3(STAT3)、蛋白激酶B(AKT)和细胞外信号调节激酶(ERK)的磷酸化。总之,这些数据表明,尽管通过EGFR/ErbB3依赖性途径,但EGFR或ErbB3的高表达在人肺腺癌细胞对PEM的细胞反应中起关键作用。

相似文献

1
Downregulation of both EGFR and ErbB3 improves the cellular response to pemetrexed in an established pemetrexed‑resistant lung adenocarcinoma A549 cell line.在已建立的培美曲塞耐药肺腺癌A549细胞系中,表皮生长因子受体(EGFR)和ErbB3的下调均改善了细胞对培美曲塞的反应。
Oncol Rep. 2014 Apr;31(4):1818-24. doi: 10.3892/or.2014.3027. Epub 2014 Feb 18.
2
Establishment of pemetrexed-resistant non-small cell lung cancer cell lines.培美曲塞耐药非小细胞肺癌细胞系的建立。
Cancer Lett. 2011 Oct 28;309(2):228-35. doi: 10.1016/j.canlet.2011.06.006. Epub 2011 Jun 24.
3
The long non-coding RNA, GAS5, enhances gefitinib-induced cell death in innate EGFR tyrosine kinase inhibitor-resistant lung adenocarcinoma cells with wide-type EGFR via downregulation of the IGF-1R expression.长链非编码RNA GAS5通过下调IGF-1R表达,增强吉非替尼对具有野生型EGFR的原发性EGFR酪氨酸激酶抑制剂耐药肺腺癌细胞的诱导细胞死亡作用。
J Hematol Oncol. 2015 Apr 29;8:43. doi: 10.1186/s13045-015-0140-6.
4
The inhibition of the pemetrexed-activated MAPK pathway via sorafenib is involved in the synergistic mechanism of sorafenib subsequent potentiation of pemetrexed cytotoxicity in EGFR TKI-resistant cell lines.索拉非尼对培美曲塞激活的MAPK通路的抑制作用参与了索拉非尼在EGFR TKI耐药细胞系中增强培美曲塞细胞毒性的协同机制。
Clin Lab. 2012;58(5-6):551-61.
5
Molecular mechanisms underlying the synergistic interaction of erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor, with the multitargeted antifolate pemetrexed in non-small-cell lung cancer cells.表皮生长因子受体酪氨酸激酶抑制剂厄洛替尼与多靶点抗叶酸药物培美曲塞在非小细胞肺癌细胞中的协同相互作用的分子机制。
Mol Pharmacol. 2008 Apr;73(4):1290-300. doi: 10.1124/mol.107.042382. Epub 2008 Jan 10.
6
Genetic determinants of pemetrexed responsiveness and nonresponsiveness in non-small cell lung cancer cells.非小细胞肺癌细胞中培美曲塞响应和无响应的遗传决定因素。
J Thorac Oncol. 2010 Aug;5(8):1143-51. doi: 10.1097/JTO.0b013e3181e0b954.
7
Combined gefitinib and pemetrexed overcome the acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer.吉非替尼与培美曲塞联合使用可克服非小细胞肺癌对表皮生长因子受体酪氨酸激酶抑制剂的获得性耐药。
Mol Med Rep. 2014 Aug;10(2):931-8. doi: 10.3892/mmr.2014.2243. Epub 2014 May 16.
8
Naphtho[1,2-b]furan-4,5-dione inactivates EGFR and PI3K/Akt signaling pathways in human lung adenocarcinoma A549 cells.萘并[1,2-b]呋喃-4,5-二酮可使人类肺腺癌细胞 A549 中的 EGFR 和 PI3K/Akt 信号通路失活。
Life Sci. 2010 Jan 30;86(5-6):207-13. doi: 10.1016/j.lfs.2009.12.006. Epub 2009 Dec 28.
9
Enhanced drug resistance in cells coexpressing ErbB2 with EGF receptor or ErbB3.与表皮生长因子受体(EGF受体)或ErbB3共表达ErbB2的细胞中增强的耐药性。
Biochem Biophys Res Commun. 2000 Nov 2;277(3):757-63. doi: 10.1006/bbrc.2000.3731.
10
High pemetrexed sensitivity of docetaxel-resistant A549 cells is mediated by TP53 status and downregulated thymidylate synthase.多西紫杉醇耐药的 A549 细胞对培美曲塞的高敏感性是由 TP53 状态和胸苷酸合成酶下调介导的。
Oncol Rep. 2017 Nov;38(5):2787-2795. doi: 10.3892/or.2017.5951. Epub 2017 Sep 7.

引用本文的文献

1
Lentinan mitigates pemetrexed chemoresistance by the PI3K/Akt pathway in non-small cell lung cancer.香菇多糖通过 PI3K/Akt 通路减轻非小细胞肺癌对培美曲塞的化疗耐药性。
Cell Biochem Biophys. 2024 Jun;82(2):1421-1431. doi: 10.1007/s12013-024-01296-8. Epub 2024 May 15.
2
SP3-induced Timeless transcription contributes to cell growth of lung adenocarcinoma cells.SP3诱导的Timeless转录促进肺腺癌细胞的生长。
PLoS One. 2024 Feb 14;19(2):e0298295. doi: 10.1371/journal.pone.0298295. eCollection 2024.
3
Chemoresistance Mechanisms in Non-Small Cell Lung Cancer-Opportunities for Drug Repurposing.
非小细胞肺癌中的化疗耐药机制——药物重新利用的机遇
Appl Biochem Biotechnol. 2024 Jul;196(7):4382-4438. doi: 10.1007/s12010-023-04595-7. Epub 2023 Sep 18.
4
Investigation of HER-3 gene expression under the influence of carbohydrate biopolymers extract of shiitake and reishi in MCF-7 cell line.探讨香菇和灵芝碳水化合物生物聚合物提取物对 MCF-7 细胞系中 HER-3 基因表达的影响。
Mol Biol Rep. 2022 Jul;49(7):6563-6572. doi: 10.1007/s11033-022-07496-w. Epub 2022 May 10.
5
Mechanisms of resistance to chemotherapy in non-small cell lung cancer.非小细胞肺癌化疗耐药的机制。
Arch Pharm Res. 2021 Feb;44(2):146-164. doi: 10.1007/s12272-021-01312-y. Epub 2021 Feb 19.
6
HER3-Receptor-Mediated STAT3 Activation Plays a Central Role in Adaptive Resistance toward Vemurafenib in Melanoma.HER3受体介导的STAT3激活在黑色素瘤对维莫非尼的适应性耐药中起核心作用。
Cancers (Basel). 2020 Dec 14;12(12):3761. doi: 10.3390/cancers12123761.
7
The deubiquitinating enzyme UCHL1 promotes resistance to pemetrexed in non-small cell lung cancer by upregulating thymidylate synthase.去泛素化酶UCHL1通过上调胸苷酸合成酶促进非小细胞肺癌对培美曲塞的耐药性。
Theranostics. 2020 May 15;10(13):6048-6060. doi: 10.7150/thno.42096. eCollection 2020.
8
Mechanisms of resistance to pemetrexed in non-small cell lung cancer.非小细胞肺癌中培美曲塞耐药的机制
Transl Lung Cancer Res. 2019 Dec;8(6):1107-1118. doi: 10.21037/tlcr.2019.10.14.
9
Augmented expression of cardiac ankyrin repeat protein is induced by pemetrexed and a possible marker for the pemetrexed resistance in mesothelioma cells.培美曲塞可诱导心肌锚蛋白重复蛋白表达增加,它可能是间皮瘤细胞中培美曲塞耐药的一个标志物。
Cancer Cell Int. 2017 Dec 11;17:120. doi: 10.1186/s12935-017-0493-8. eCollection 2017.